InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Rapamycin | Jatrophane Diterpenoids from Euphorbia peplus Linn. as Activators of Autophag... | 2023 | Int J Mol Sci. | Yan Y. et al. | DOI: 10.3390/ijms24021088 |
| CLI-095 | P. gingivalis-LPS Induces Mitochondrial Dysfunction Mediated by Neuroinflamma... | 2023 | Int J Mol Sci. | Verma A. et al. | DOI: 10.3390/ijms24020950 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | P. gingivalis-LPS Induces Mitochondrial Dysfunction Mediated by Neuroinflamma... | 2023 | Int J Mol Sci. | Verma A. et al. | DOI: 10.3390/ijms24020950 |
| Alhydrogel® adjuvant 2% | Leptospira borgpetersenii Leucine-Rich Repeat Proteins Provide Strong Protect... | 2023 | Trop Med Infect Dis. | Prapong S. et al. | DOI: 10.3390/tropicalmed8010006 |
| WGP - Whole Glucan Particles | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| HEK-Blue™ hDectin-1b Cells | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| Puromycin | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| Normocin® - Antimicrobial Reagent | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| QUANTI-Blue™ | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| HEK-Blue™ Detection | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| Zymosan | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| HEK-Blue™ CLR Selection | Feasibility of Brewer's Spent Yeast Microcapsules as Targeted Oral Carriers. | 2023 | Foods | Reis S.F. et al. | DOI: 10.3390/foods12020246 |
| CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes | Trilayered Gires-Tournois Resonator with Ultrasensitive Slow-Light Condition ... | 2023 | Nanomaterials (Basel). | Kang J. et al. | DOI: 10.3390/nano13020319 |
| Original strain - His-tagged RBD Protein | Trilayered Gires-Tournois Resonator with Ultrasensitive Slow-Light Condition ... | 2023 | Nanomaterials (Basel). | Kang J. et al. | DOI: 10.3390/nano13020319 |
| Poly(I:C) (HMW) VacciGrade™ | Toll-like Receptor 3 in the Hybrid Yellow Catfish ( Pelteobagrus fulvidraco ♀... | 2023 | Animals (Basel). | Guo S. et al. | DOI: 10.3390/ani13020288 |
| AddaVax™ | A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction ... | 2023 | Vaccines (Basel). | Goksøyr L. et al. | DOI: 10.3390/vaccines11010002 |
| Normocin® - Antimicrobial Reagent | Anti-Inflammatory Role of TRPV4 in Human Macrophages. | 2023 | Immunohorizons | Atsumi Y. et al. | DOI: 10.4049/immunohorizons.2200100 |
| Blasticidin | Anti-Inflammatory Role of TRPV4 in Human Macrophages. | 2023 | Immunohorizons | Atsumi Y. et al. | DOI: 10.4049/immunohorizons.2200100 |
| Hygromycin B Gold | Anti-Inflammatory Role of TRPV4 in Human Macrophages. | 2023 | Immunohorizons | Atsumi Y. et al. | DOI: 10.4049/immunohorizons.2200100 |
| Plasmocin® - Mycoplasma Elimination Reagent | Endosomal escape of nucleic acids from extracellular vesicles mediates functi... | 2023 | Pharmacol Res. | Thach T. et al. | DOI: 10.1016/j.phrs.2023.106665 |